Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus

The scarcity of novel antibiotic compounds in a time of increasing resistance rates has begun to ring alarm bells at the highest echelons of government. Large new financial incentives to accelerate antibiotic research and development, such as market entry rewards (MERs), are being considered. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Morel, Chantal M., Lindahl, Olof, Harbarth, Stephan, de Kraker, Marlieke E. A., Edwards, Suzanne, Hollis, Aidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292800/
https://www.ncbi.nlm.nih.gov/pubmed/32203126
http://dx.doi.org/10.1038/s41429-020-0300-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292800/
https://www.ncbi.nlm.nih.gov/pubmed/32203126
http://dx.doi.org/10.1038/s41429-020-0300-y

Ejemplares similares